New York, NY -- (SBWIRE) -- 12/04/2013 -- Growing Stock Report expands its NASDAQ Active Stock Weekly Watch List adding Fortinet Inc. (NASDAQ:FTNT) and Clovis Oncology, Inc. (NASDAQ:CLVS).
Fortinet Inc. (NASDAQ:FTNT) a company that provides network security solutions worldwide closed up in its previous session (+2.81%) on 4,727,074 shares traded after Fortinet today announced that it would extend its relationship with Willis College of Business, Technology and Healthcare in Ottawa in order to train future employees. Fortinet Inc. (NASDAQ:FTNT) is currently up (+8.23%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Active Stock Watch List.
Click Here to find out what other Investors are saying about Fortinet Inc. (NASDAQ:FTNT)
Clovis Oncology, Inc. (NASDAQ:CLVS) a biopharmaceutical company that focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally closed down in its previous session (-5.02%) on 2,101,105 shares traded after Clovis Oncology, Inc. announced the pricing of an underwritten public offering of 2,000,000 shares of its common stock at a price to the public of $57.50 per share. Clovis Oncology, Inc. (NASDAQ:CLVS) is currently down (-35.87%) from its recent 52-week high which has prompted Growing Stock Report to add the stock to their NASDAQ Active Stock Watch List.
Click Here to find out what other Investors are saying about Clovis Oncology, Inc. (NASDAQ:CLVS)
GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.
Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.
Timing is important when trading Small Caps and Penny Stocks.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.GrowingStockReport.com
GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.
Growing Stock Report